These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3927851)

  • 1. [Comparison of the concentration of HCFU, tegafur and 5-FU in the thoracic duct lymph after oral administration of HCFU and tegafur].
    Matsumoto S; Nagai K; Sugimoto T; Kutsuna T; Nomoto S; Yoshizaki S
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1697-8. PubMed ID: 3927851
    [No Abstract]   [Full Text] [Related]  

  • 2. [Blood level of 5-fluorouracil (5-FU) by oral administration of 1-hexylcarbamoyl-5-fluorouracil (HCFU) and tegafur in patients with hepatocellular carcinoma].
    Onji M; Kondo H; Yamashita Y; Ohta Y; Mori K; Fuse M
    Nihon Gan Chiryo Gakkai Shi; 1985 Oct; 20(9):2063-72. PubMed ID: 3005446
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticancer drug distribution in lymph and blood during adjuvant chemotherapy after surgery for gastric carcinoma. A study with a combined preparation of 1-(2-tetrahydrofuryl)-5-fluorouracil and uracil.
    Hanaue H; Kurosawa T; Kitano Y; Miyakawa S; Nemoto A; Yamamoto H; Asagoe T; Takada T; Yasuda H; Shikata J
    Cancer; 1987 May; 59(9):1571-6. PubMed ID: 3103905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison between FT-207 and 5-FU on intravesical absorption--experimental study on intravesical absorption in the dog].
    Nakagawa S; Kobayashi T; Nakao M; Toyoda K; Mishina T; Miyakoda K
    Hinyokika Kiyo; 1985 Jul; 31(7):1227-31. PubMed ID: 3933286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influence of immunopotentiators on the activation of 5-FU derivatives].
    Nakazato H; Kito T; Yasue M; Yamamura Y; Kobari T; Hirakawa T; Hatta M
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):867-74. PubMed ID: 3920971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sequential changes in blood concentrations of tegafur and 5-FU during oral administration of fine granules of tegafur in patients with primary liver cancer].
    Onji M; Yamashita Y; Horiike N; Kanaoka M; Ohta Y; Yoshida T; Hattori M
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):480-8. PubMed ID: 6307183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on the concentration of FT-207 and 5-FU in serum, lymph nodes and tissues after administration of FT-207 suppositories].
    Kumazawa H; Imai N; Shioya M; Kato K; Fukaya Y; Noguchi A
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1655-62. PubMed ID: 6433799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [5-Fluorouracil, tegafur, and uracil concentrations in serum and tissue of the patients with hepatocellular carcinoma after UFT administration].
    Suenaga M
    Gan To Kagaku Ryoho; 1987 Dec; 14(12):3313-8. PubMed ID: 2825604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic fate of 1-hexylcarbamoyl-5-fluorouracil after oral administration in mice.
    Iigo M; Nakamura A; Kuretani K; Hoshi A
    Xenobiotica; 1980 Nov; 10(11):847-54. PubMed ID: 7467400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized controlled trial of the efficacy of adjuvant immunochemotherapy and adjuvant chemotherapy for colorectal cancer, using different combinations of the intracutaneous streptococcal preparation OK-432 and the oral pyrimidines 1-hexylcarbamoyl-5-fluorouracil and uracil/tegafur.
    Watanabe M; Nishida O; Kunii Y; Kodaira S; Takahashi T; Tominaga T; Hojyo K; Kato T; Niimoto M; Kunitomo K; Isomoto H; Ohashi Y; Yasutomi M
    Int J Clin Oncol; 2004 Apr; 9(2):98-106. PubMed ID: 15108041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [FT-207 and 5-FU concentrations in brain tumor tissues, plasma and CSF after administration of FT-207 suppository].
    Matsuura H; Nakazawa S
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):912-6. PubMed ID: 6426399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A randomized controlled study to compare 1-hexylcarbamoyl-5-fluorouracil (HCFU) and 1-(2-tetrahydrofuryl)-5-fluorouracil (Tegafur) for the prevention of post-operative recurrence of bladder cancer].
    Misaki T; Hisazumi H; Sakai A; Nakamura T; Kanda S; Mikawa I; Miyagi T; Katsumi T; Orito M; Kawaguchi K
    Hinyokika Kiyo; 1985 Jul; 31(7):1233-41. PubMed ID: 3933287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [5-FU concentration in blood and tissue of patients with primary lung cancer after oral administration of UFT].
    Oiwa T; Saito H
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):525-30. PubMed ID: 3082289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma, intestine and tumor levels of 5-fluorouracil in mice bearing L1210 ascites tumor following oral administration of 5-fluorouracil, UFT (mixed compound of tegafur and uracil), carmofur and 5'-deoxy-5-fluorouridine.
    Ooi A; Ohkubo T; Higashigawa M; Kawasaki H; Kakito H; Kagawa Y; Kojima M; Sakurai M
    Biol Pharm Bull; 2001 Nov; 24(11):1329-31. PubMed ID: 11725974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of 1-(2-tetrahydrofuryl)-5-fluorouracil to 5-fluorouracil in partially hepatectomized rats.
    Maehara Y; Takahashi I; Yoshida M; Emi Y; Baba H; Kusumoto H; Kohnoe S; Sugimachi K
    Anticancer Drugs; 1992 Apr; 3(2):117-20. PubMed ID: 1525388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N1-(2 tetrahydrofuryl)-5-fluorouracil (FT-207) in the postoperative adjuvant chemotherapy of gastric cancer. Delivery of a fat-emulsified agent to the lymph.
    Hanaue H; Kurosawa T; Kitano Y; Miyakawa S; Horie F; Nemoto A; Shikata J
    Cancer; 1986 Feb; 57(4):693-8. PubMed ID: 3080217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical study on concentration of FT-207 and 5-FU in serum, lymph nodes and tissues after rectal administration of FT-207 suppositories for malignant diseases of the liver, biliary tract and pancreas].
    Takada T; Yasuda H; Uchiyama K; Hasegawa H
    Gan To Kagaku Ryoho; 1985 May; 12(5):1088-93. PubMed ID: 3922311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [5-FU, FT-207 and uracil concentrations in the serum and tissues of patients with cervical cancer after UFT oral administration].
    Tanimura T; Kaneshige E; Fujiwara K; Kobashi Y; Inoue K; Kono I; Sekiba K
    Gan To Kagaku Ryoho; 1986 Feb; 13(2):349-55. PubMed ID: 3080967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of urokinase on the transfer of 1-hexylcarbamoyl-5-fluorouracil (HCFU) into the blood, bile and pancreatic juice].
    Kato S; Matsuno S; Kakizaki K; Fukaya Y; Akaishi S
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2134-8. PubMed ID: 4062312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Human colorectal carcinoma is more sensitive to HCFU than 5-FU and tegafur in in vitro and in vivo drug sensitivity tests].
    Kusumoto T; Maehara Y; Anai H; Kusumoto H; Miyamoto K; Fukuchi K; Sugimachi K
    Gan To Kagaku Ryoho; 1988 Feb; 15(2):257-61. PubMed ID: 3124767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.